GlassScriptPhysician profile
Lery Bonnin
NPI 1437668662
$2,123.59
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $36.60 · 2021: $261 · 2022: $1,108 · 2023: $638 · 2024: $79.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.59 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $1,442.67 | 2020-2024 | |
| Align Technology, INC. | $552.63 | 2021-2024 | Itero Element 5d Plus, Invisalign |
| Orapharma, A Division of Bausch Health US, LLC | $55.79 | 2021-2023 | Arestin |
| Kerr Corporation | $37.69 | 2021-2023 | Optibond All-In-One |
| Nobel Biocare USA | $19.43 | 2023 | Nobelactive |
| Voco America INC. | $15.38 | 2024 | Meron Plus Qm, Admira Fusion X-Tra, Voco Profluorid Varnish |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lery Bonnin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.